Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : STEM -- StemCells, Inc. -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (195)	1/25/1999 7:51:00 PM
From: WWS	Read Replies (2) \| Respond to of 805

Richard, I must admit to not knowing as much as I should about the status of immune response systems within the CNS. But didn't Schwartz in Israel discover that the blood brain barrier pretty much insulates and isolates the CNS from the immune system? And didn't some of the earliest experimental clinical work in Sweden involve transplanting immature neurons from fetal pig brains (substantia nigra region of the midbrain) into dopaminergic brain areas of humans suffering from parkinsonism (both idiopathic and accidently induced types)? If memory serves, this allogenic transplanted material wasn't rejected.